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ABSTRACT
Cobalamin-dependent methionine synthase catalyzes
the transfer of a methyl group from N5-methyltetra-
hydrofolate to homocysteine, producing tetrahydro-
folate and methionine. Insufficient availability of
cobalamin, or inhibition of methionine synthase by ex-
posure to nitrous oxide, leads to diminished activity of
this enzyme. In humans, severe inhibition of methio-
nine synthase results in the development of megalo-
blastic anemia, and eventually in subacute combined
degeneration of the spinal cord. It also results in
diminished intracellular folate levels and a redistribu-
tion of folate derivatives. In this review, we summarize
recent progress in understanding the catalysis and
regulation of this important enzyme from both bac-
terial and mammalian sources. Because inhibition of
mammalian methionine synthase can restrict the in-
corporation of methyltetrahydrofolate from the blood
into cellular folate pools that can be used for nucleotide
biosynthesis, it is a potential chemotherapeutic target.
The review emphasizes the mechanistic information
that will be needed in order to design rational inhibi-
tors of the enzyme. -BANERJEE, R. V.; MATTHEWS,
R. G. Cobalamin-dependent methionine synthase.
FASEBJ 4: 1450-1459; 1990.
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METHIONINE SYNTHASE (5-methyltetrahydrofolate-homo-
cysteine methyltransferase) (EC 2.i.i.13) catalyzes the
transfer of a methyl group from methyltetrahydrofolate
(CH3 - H4folate)1 to homocysteine, generating H4folate
and methionine as shown in Eq. 1.
CH3-H4folatc + Homocysteine-’H4folate + Methioninc (1)
In prokaryotes that synthesize methionine de novo, this
reaction represents the terminal step in methionine bio-
synthesis. Methionine synthase is thus poised at the
point of convergence of two major biosynthetic path-
ways: the tetrahydrofolate-dependent pathway for bio-
synthesis of methyl groups and the homocysteine bio-
synthetic pathway. Mammals, on the other hand, are
unable to synthesize homocysteine de novo; rather they
use methionine synthase to regenerate methionine
from homocysteine to provide one-carbon units for S-
adenosylmethionine (AdoMet)-dependent methylation
reactions.
Escherichia co/i synthesize two distinct proteins with
methionine synthase activity. The metH gene product is
a cobalamin-dependent enzyme (EC 2.1.1.13) that uses
monoglutamate as well as polyglutamate forms of
CH3-H4 folate as substrates, and must be activated for
catalysis by a reductive methylation involving AdoMet
and an electron donor (i, 2). The metE gene product is a
cobalamin-independent form of the enzyme (5-methyl-
tetrahydropteroyltriglutamate-homocysteine methyltrans-
ferase, EC 2.i.i.14) that has a strict requirement for the
polyglutamate form of the substrate CH3 - H4folate
(3). In vitro assays can easily distinguish between the
two activities; MetE requires magnesium and phos-
phate ions for activity (3), whereas MetH has an abso-
lute requirement for AdoMet and a reducing system
(2). In addition, the standard assay for cobalamin-
dependent methionine synthase includes the mono-
glutamate form of CH3-H4folate and thereby ex-
cludes reaction of MetE.
Although the prokaryotic cobalamin-dependent me-
thionine synthase has been studied extensively (re-
viewed in refs 4 and 5), the mammalian enzyme is
much less well characterized. The metH gene from
E. coil has been cloned and its gene product overex-
pressed (6). The mammalian enzyme appears very
similar in its catalytic properties to the metH gene
product from E. co/i. Thus, the mammalian enzyme
also contains cobalamin (7) and is competent to react
with the monoglutamate form of CH3 - H4folate. It,
too, is isolated in an inactive form and requires
AdoMet-dependent reductive methylation for activa-
tion (7). The apparent similarity of the catalytic
mechanisms of the cobalamin-dependent enzymes
from bacterial and mammalian sources, and the ready
availability of the bacterial MetH protein, make this
enzyme an attractive choice for mechanistic studies.
In this review, we begin by presenting a brief over-
view of methionine synthase and its role in folate
‘Abbreviations: AdoMet, S-adenosyl-L-methionine; CH3 - H4fo-
late, N5-methyltetrahydrofolate; C H2 - H4folate, N5 ,N ‘#{176}-methylene-
tetrahydrofolate; AdoHCy, S-adenosyl-L-homocysteine; kDa, kilo-
dalton; HCy, homocysteine; CH = H4folate, N5,N ‘#{176}-methenyltetra-
hydrofolate; CHO- H4folate; N’#{176}-formyltetrahydrofolate; H2folate,
dihydrofolate; bp, base pairs.
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metabolism and then consider the mammalian enzyme
as a potential target for chemotherapeutic intervention.
The inactivation of enzyme from both mammalian and
bacterial sources by nitrous oxide (N2O) is discussed.
Studies of the nucleotide sequence analysis of the metH
gene and structure-function studies of the encoded pro-
tein are summarized. Finally, salient chemical prob-
lems associated with catalysis of this methyl transfer
reaction are discussed within the framework of a possi-
ble mechanism of catalysis.
OVERVIEW OF METHIONINE SYNTHASE AND
ITS ROLE IN FOLATE METABOLISM
The pioneering studies by du Vigneaud and co-workers
(8) and by Bennett (9) demonstrated that dietary re-
quirements for methionine in the rat could be replaced
by supplying homocysteine and cyanocobalamin. Studies
from the laboratories of Buchanan, Kisliuk, and Woods
(reviewed in refs 4 and 5) demonstrated the presence of
a cobalamin cofactor in methionine synthase purified
from both E. co/i and pig liver.
The structure of the cobalamin cofactor of methionine
synthase is shown in Fig. 1. The cobalt ion in cobalamin
is coordinated by four coplanar nitrogen ligands in a
reduced tetrapyrrole structure, the corrin ring. Two
additional coordination sites exist: the upper and lower
axial positions that lie above and below the plane of the
ring, respectively. In methylcobalamin, a methyl group
is bonded to cobalt in the upper axial position, and the
R = CH2CONH2
R’= CH2CH2CONH2
Figure 1. Structure of the cobalamin cofactor of methionine syn-
thase. The structure drawn is that of methylcobalamin, with the
methyl group occupying the upper axial coordination site of cobalt.
lower axial position is occupied by a nitrogen of the di-
methylbenzimidazole nucleotide substituent of the cor-
rin ring. During turnover, the cobalamin cofactor of
methionine synthase shuttles between methylcobalamin
and cob(I)alamin (which contains a pair of electrons in
the dz2 orbital oriented perpendicularly to the plane of
the corrin ring). The enzyme-bound cob(I)alamin can
be oxidized to cob(II)alamin, with a single electron in
the dz2 orbital, or to cob(III)alamin. The different
forms of cobalamin can readily be distinguished by
their ultraviolet and visible electronic absorbance spec-
tra (Fig. 2).
The cobalamin-dependent enzyme from E. coil B was
extensively purified by Taylor and Weissbach (10) and
was purified to homogeneity from E. co/i K-12 by Fujii
and Huennekens (ii). Studies from these two labora-
tories, and from those of Kisliuk and Woods (reviewed
in refs 4, 5), suggested the catalytic mechanism shown
in Fig. 3, in which the enzyme cycles during turnover
between methylcobalamin and cob(I)alamin. The par-
ticipation of methyl cobalamin as a catalytic intermedi-
ate was demonstrated by radiolabel tracer studies (12).
Cob(I)alamin was formed by demethylation of meth-
ylated enzyme under anaerobic conditions, as deduced
by characteristic changes in the visible electronic absor-
bance spectrum when homocysteine was added to the
enzyme-bound methylcobalamin (13, i4).
Concomitant studies of the enzymes involved in the
conversion of the fl-carbon of serine into the methyl group
of AdoMet (Fig. 4) elucidated the regulation of AdoMet
biosynthesis. Serine hydroxymethyltransferase catalyzes
the transfer of the fl-carbon of serine to H4folate to gener-
ate CH2- H4folate and glycine. Methylenetetrahydro-
folate reductase (NADPH) (EC 1.5.i.20) catalyzes the
reduction of CH2-H4folate to CH3-H4folate. The
overall NADPH-linked reduction of CH2 - H4folate to
CH3-H4folate is irreversible (iS) and commits folate-
bound one-carbon units to use for the methylation of
homocysteine. Methionine synthase catalyzes the transfer
of the methyl group of CH3 - H4folate to homocysteine
MetAdoMet AdoilCy
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Figure 3. Schematic mechanism for activation and catalysis of
methionine synthase. The cob(II)alamin form of the enzyme is in-
active. In vitro activation involves a reductive methylation with
AdoMet as the methyl donor. The methylated enzyme, once
formed, is catalytically active and cycles between cob(I)alamin and
methylcobalamin in catalysis, as shown. Occasional oxidation of the
cob(I)alamin intermediate to the inactive cob(II)alamin mandates
the continuing requirement for the activation system during
catalysis.
to form methionine and H4folate, and methionine can
then be used for protein synthesis or converted to
AdoMet. In mammals, this pathway is regulated by the
AdoMet/AdoHCy ratio, and AdoMet has been shown
to be an allosteric inhibitor of methylenetetrahydrofolate
reductase from mammalian sources (16, 17). AdoHCy,
the product of AdoMet-dependent methylation reac-
tions, blocks the binding of AdoMet to methylenetetra-
hydrofolate reductase, but does not itself inhibit or acti-
vate the enzyme. In E. co/i, AdoMet, rather than
methionine, is also the major regulator of methionine
biosynthesis and combines with an aporepressor pro-
tein, the metJ gene product, to inhibit transcription of
enzymes involved in methionine biosynthesis (reviewed
in ref 18).
Inhibition of methionine synthase interferes with
AdoMet-dependent regulation of the cellular levels of
CH3-H4folate. Under these circumstances, inade-
quate intake of dietary methionine leads to a fall in
AdoMet concentrations that can no longer be pre-
vented by remethylation of homocysteine. Methylene-
tetrahydrofolate reductase remains fully active, and cel-
lular folates accumulate as CH3 - H4folate. These
changes result in a cellular methyl trap as first proposed
by Noronha and Silverman (19) and by Herbert and
Zaluskey (20). Cobalamin deficiency also leads to an
accumulation of the C H3 - H4folate pool at the expense
of the other cellular folate pools owing to the decreased
activity of methionine synthase. The depletion of
CH2 - H4folate required for thymidylate biosynthesis
appears to be the primary cause of megaloblastic ane-
mia associated with either folate or cobalamin defi-
ciency in humans. Megaloblastic anemia is not asso-
ciated with folate or cobalamin deficiency in other
mammals.
Inhibition of methionine synthase leads not only to
redistribution of cellular folate derivatives, but also to
a decline in the total intracellular folate level. The
major circulating form of folate is C H3 - H4folate, and
methionine synthase activity is required to convert this
derivative to forms that can be used for nucleotide bio-
synthesis (15). Moreover, CH3-H4folate is a poor sub-
strate for folylpolyglutamate synthase (21), the enzyme
that catalyzes sequential poly-y-glutamylation of intra-
cellular folate derivatives to generate folylpolygluta-
mates, which are the predominant intracellular forms
of folic acid. The polyglutamate forms of folic acid are
essential for intracellular retention of the vitamin.
Hence a shift in the cellular folate pool to methyl
derivatives results in a shift toward shorter-chain forms
that can traverse the cell membrane more readily and
lead to an intracellular folate deficiency.
CH3.H4folate
Blood
Cytoplasm
NADPH
CH=H4folate
H20
CHO-H4folate 9, 10 #{149}purine biosynthesis
ADP+ Pi
HCOOH
H4folate
Figure 4. Outline of the major tetrahydrofolate-dependent biosyn-
thetic pathways. The enzymes involved are: 1, methyltetrahydro-
folate-homocysteine methyltransferase (methionine synthase); 2,
serine hydroxymethyltransferase; 3, thymidyiate synthase; 4, di-
hydrofolate reductase; 5, methylenetetrahydrofolate reductase; 6,
methylenetetrahydrofolate dehydrogenase; 7, methenyltetrahydro-
folate cyclohydrolase; 8, formyltetrahydrofolate synthetase; 9,
glycineamide ribonucleotide transformylase; 10, aminoimidazole-
carboxamide ribonucleotide transformylase; 11, adenosylmethio-
nine synthetase; 12, adenosylmethionine-dependent methyltrans-
ferases; and 13, adenosylhomocystemne hydrolase.
(2)
(3)
COBALAMIN-DEPENDENT METHIONINE SYNTHASE 1453
Methionine synthase thus may be viewed as a crucial
player in folate metabolism, poised at the point of entry
of folates into the cell and responsible for converting the
vitamin from CH3 - H4folate into a more widely useful
form that can participate in nucleotide biosynthesis.
Methionine, the other product of the methionine
synthase-catalyzecl reaction, is an essential amino acid
in mammals, and serves in protein synthesis and as the
precursor for AdoMet. The latter is a crucial methyl
group donor involved in the biosynthesis of a variety of
compounds including creatine, phosphatidylcholine,
and epinephrine. AdoMet shortage in cells lacking ac-
tive methionine synthase may be alleviated by the pro-
vision of exogenous methionine, whereas conversion of
CH3-H4folate to H4folate would remain compro-
mised. Methylenetetrahydrofolate reductase activity
should remain inhibited under this regime, preventing
the accumulation of cellular folylpolyglutamates as
CH3 - H4folate.
The relationship between impaired methionine syn-
thase activity and diminution of cellular folate pools
should make it an attractive chemotherapeutic target.
Rapidly dividing cells should have an elevated require-
ment for uptake of folate from the blood, and may be
particularly hard hit by inhibition of methionine syn-
thase. Several enzymes involved in folate metabolism,
including thymidylate synthase and dihydrofolate re-
ductase, have already been realized as chemotherapeutic
targets. Inhibition of methionine synthase, with its
potential for depleting the folate pool with consequent
inhibition of nucleotide biosynthesis, holds a similar
promise. As yet no antineoplastic drug directed against
methionine synthase is available.
INACTIVATION OF METHIONINE SYNTHASE
BY NITROUS OXIDE
Exposure of humans to nitrous oxide (N2O), a com-
monly used anesthetic agent, leads to inactivation of
methionine synthase (22). Prolonged exposure leads to
the development of megaloblastic anemia in humans
but not in other mammals (23), and in cases of repeated
exposure may even result in the neurological symptoms
characteristic of pernicious anemia or cobalamin defi-
ciency, such as subacute combined degeneration of the
spinal cord (24). Treatment of rodents with N2O has
been shown to lead to a rapid decrease in the levels of
methionine synthase activity in liver homogenates
(25-27). Recovery of activity required several days after
discontinuation of N2O treatment and presumably was
linked to synthesis of new enzyme. Long-term adminis-
tration of N20 to monkeys resulted in subacute com-
bined degeneration of the spinal cord, and these symp-
toms could be alleviated by methionine supplementation
of the diet (28). Since the effect of nitrous oxide appears
to be specific for methionine synthase, an understand-
ing of the events associated with this inactivation might
point the way to the design of other inhibitors of
methionine synthase.
Model studies of the interaction of the cob(I)alamin
in aqueous solution with N2O have established that
cob(I)alamin is oxidized and N2 is liberated (29, 30),
presumably according to Eq. 2 and 3.
cob(I)alamin + N20 + 2Hcob(III)alamin + N2 + H2O
cob(III)alamin + cob(I)alamin - 2cob(II)alamin
As these experiments were conducted in the presence of
an excess of cob(I)alamin, the formation of cob(III)ala-
mm was not directly demonstrated but was implied
from the observed formation of cob(II)alamin.
The similarity of cobalamin-dependent methionine
synthase enzymes from prokaryotic and eukaryotic
sources extends to their susceptibility to inhibition by
N2O. Purified methionine synthase preparations from
E. co/i B and from pig liver have been used to demon-
strate the in vitro inactivation of the enzyme by N20
(31). Inactivation occurred only in the presence of all
components required for turnover. The ratio of moles
of methionine formed to moles of enzyme inactivated
was approximately 3900 for the bacterial enzyme. Pre-
sumably because of the requirement for multiple turn-
overs per inactivation event, inactivation occurred only
in very dilute enzyme solutions (-6 nM enzyme), so
that absorbance changes associated with enzyme in-
activation could not be monitored directly. When the
inactivated enzyme was reconcentrated from the assay
solution so that its absorbance properties could be
examined, significant loss of the cobalamin was ob-
served in the N20-treated enzyme as compared to con-
trol N2-treated enzyme, but both samples retained the
spectrum of cob(II)alamin. Based on the model studies,
it was postulated that N2O intercepts enzyme-bound
cob(I)alamin that is generated transiently during turn-
over, with formation of cob(II)alamin and hydroxyl
radical as shown in Eq. 4. Generation of a rogue
hydroxyl radical at the active site could explain the ob-
served irreversible loss of enzyme activity.
cob(I)alamin + N20 + H-’cob(II)alamin + N2 + OH (4)
Studies aimed at directly monitoring the reaction of en-
zyme bound cob(I)alamin with N2O are in progress in
our laboratory.
CLONING AND SEQUENCE ANALYSIS OF THE
METH GENE
In E. coil, methionine synthase catalyzes the terminal
step in the de novo biosynthesis of methionine. Under
conditions of aerobic growth the bacteria are unable to
synthesize cobalamin, although the MetH apoenzyme is
synthesized. In the absence of methionine or cobalamin
in the medium, aerobic cell growth requires the MetE
protein. When coablamin is added to the medium, the
MetH holoenzyme is formed and MetE synthesis is re-
pressed. A methionine-requiring nutritional auxotroph
of E. co/i (RK4536: metI-t, metE) was used to isolate a
recombinant clone that was prototrophic for methio-
nine in the presence of cobalamin (32, 33). The identity
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of the cloned metH gene was confirmed by nucleotide
sequence analysis, maxicell expression, and enzyme ac-
tivity assays. The sequence of both strands was com-
pletely determined, including 220 bp upstream and 180
bp downstream of the protein coding sequence (6). The
open reading frame encodes 1,124 amino acids with a
predicted molecular mass of 123,640 daltons, within
9% of the value given by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and by gel filtration
(34). More recently, the nucleotide sequence of the
metH gene from E. co/i K-12 has been determined (35)
and a 3600-bp open reading frame that encodes a pep-
tide with a predicted molecular weight of 132,628 was
found. The amino acid sequence deduced by the two
groups diverges at position 3337. The difference ap-
pears to result from omission of a G from the sequence
TGGGG starting at position 3334, which results in a
stop codon at position 3374 of the shorter open reading
frame. The validity of the COOH-terminal extension
was established by the expression of fl-galactosidase ac-
tivity by a metH-iacZ fusion located 190 bp downstream
of the putative stop codon at position 3374 (35).
Comparison of the deduced amino acid sequences of
the E. coil metH gene and the proximal third of the
Salmonella metH gene (36) revealed a remarkable
similarity, with only 21 of the 371 amino acids being
different. In contrast, comparison with all other se-
quences in the NBRF and GenBank databases failed to
identify any significant homologies. Both metH and
metE genes have been shown to be subject to positive
regulation by the meiR gene product, a trans-acting
transcriptional activator (37, 38). Although no exten-
sive regions of homology are apparent in the sequences
of the metE and metH control regions of Salmonella
lyphimurium, a short region of interrupted dyad sym-
metry was found (36). Mutations in this region of the
metE gene disrupt the normal regulation of the metE
gene by the meiR gene product (36). The metR gene
product has been shown to bind to an upstream region
in the E. coil metE gene (39). Upstream of the E. co/i
metH gene a similar sequence has been found (35, 40).
The four sequences are shown in Fig. 5. The finding
of only partial homology between the control regions of
the two genes is not surprising, since they are regulated
to vastly different extents by the metR gene product
(36). Hence, although the range of activation of the
metE gene is nearly 100-fold, that of the metH gene is
only five- to sixfold. The observation that the dyadic
symmetry is more extensive in the two metE sequences
than in the analogous metH sequences is consistent with
the differential effect of the metR gene on transcrip-
tional regulation of these two genes.
THE COBALAMIN-BINDING DOMAIN: AN a/fl
STRUCTURE?
Since primary sequence comparison of MetH with
other folate- and cobalamin-binding proteins failed to
reveal any significant relationship, we sought to use
limited proteolysis to identify a fragment of the enzyme
E.colime:H ATGTTGAACAAATCTCATGTTGCG
Salmonella met!! AAGCTGAACATGTCTCATCTTGCC
Salmonella metE ATCATGAAACTCCTTCAcTTCGCC
E.coli metE AT CAT GA A ACT CC T T C ACT T CG GC
-
Figure 5. Comparison of the upstream sequences of the metE and
metH genes that are presumably involved in regulation by metR. The
regions compared show the interrupted dyad symmetry sequence;
mutations in this region disrupt the normal regulation of the metE
gene by the metR gene product in Salmonella (36). Residues con-
served in all four genes are shown in bold type. Each of the
sequences is upstream of the corresponding -35 region of its gene.
The direction of transcription of all three genes is to the right. The
papers from which these sequences are drawn are noted in the text.
containing the cobalamin-binding site (6). Tryptic
digestion of the native recombinant enzyme resulted in
the formation of two daughter fragments of 95 and 35
kDa, and was accompanied by loss of activity. NH2-
terminal sequence analysis of the 35-kDa fragment es-
tablished its position at the COOH-terminal end of the
protein. Although the 35-kDa fragment was fairly stable
over the time course of the digestion, the 95-kDa pep-
tide was cleaved to form 68- and 28-kDa peptides. Sep-
aration of the peptides on a native nondenaturing gel
resulted in the identification of a pink fragment that re-
tained the cobalamin-binding site and had a molecular
mass of 28,000. NH2-terminal analysis of the 28-kDa
fragment established the limits of the cobalamin-
binding domain. The hypersensitive site at the COOH-
terminus of the cobalamin-binding domain, between
residues 900 and 901, lies in one of the most hydrophilic
internal regions of the protein as predicted by the
method of Kyte and Doolittle (41). The 28-kDa frag-
ment is immediately upstream of the 35-kDa fragment,
and is characterized by the prevalence of hydrophobic
residues.
Comparison of the deduced sequence of the 28-kDa
fragment with those of other soluble cobalamin-
binding proteins such as BtuR (a cobalamin-binding
protein from E. co/i implicated in the metabolism of
adenosylmethionine) (42), MutA and MutB (the two
subunits of methylmalonyl CoA mutase from Propioni-
bacterium shermanli) (43), and Ea1A and Ea1B (the two
subunits of ethanolamine ammonia lyase from Sal-
monella typhirnurium) (L. P. Faust, J. A. Connor, D. M.
Roof, J. A. Hoch, and B. M. Babior, unpublished
results), failed to detect any significant homologies.
However, predicted secondary structure comparisons
of the four proteins revealed a striking similarity in the
pattern and spacing of alternating a-helices and /3-
sheets spanning a length of about 100 amino acids in
the deduced sequences of each of the four proteins, as
shown in Fig. 6. In the absence of a crystal structure
for any member of the cobalamin-binding protein
family, it was postulated that the cobalamin pocket may
contain an a/fl type of structure (6). The alternation of
a-helices and fl-sheets is suggestive of the Rossman fold
motif that is involved in binding nucleotides (44). The
structure of cobalamin contains dimethylbenzimida-
zole in an unusual nucleotide. A comparison of the
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Figure 6. Predicted secondary structure comparisons of segments of four cobalamin-binding proteins. A, Residues 800-900 of MetH (6);
B, residues 96-196 of BtuR (42); C, residues 505-605 of MutB (43); D, residues 110-210 of EaIB (B. M. Babior, personal communication).
CF, Chou-Fasman secondary structure prediction; GOR, Garnier-Osguthorpe-Robson secondary structure prediction. The thickness of
the black bars is proportional to the strength of the prediction.
benzimidazole-ribofuranosyl portion of cobalamin with
the adenine ribose of NAD bound to crystalline malate
dehydrogenase revealed a good alignment of the two
molecules with a calculated root mean square distance
between corresponding atoms of 1.05 A (45). The
region of identified secondary structural homology in
the cobalamin-binding proteins may be involved in
docking the dimethylbenzimidazole nucleotide.
Conservation of secondary and tertiary structure in
binding domains in the absence of primary sequence
conservation is not without precedent. Hence, in the
globins and cytochromes, peptides with poor primary
sequence homology fold into proteins of striking archi-
tectural similarity. In the globins, for instance, the
pocket in which the heme cofactor binds is created by
the assembly of eight a-helices. Only 5 of the 116 posi-
tions that are involved in conserved interactions with
the cofactor are identical in all globins, and even they
are not contiguous in the primary sequence (46). This
illustrates the difficulty in predicting the relatedness of
the globin family members from primary sequence
comparisons alone.
ACTIVATION OF METHIONINE SYNTHASE
AND ITS CATALYTIC MECHANISM
The properties of the E. co/i B enzyme that has been
purified to homogeneity (34) are similar to those de-
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scribed for the partially purified enzyme from the same
source (10) and for the homogeneous wild-type (11) and
recombinant (6) enzymes from E. coli K-12. The en-
zyme is monomeric, and contains 1 mol of cobalamin
per mol of enzyme. Electron spin resonance (EPR)
spectroscopy of the enzyme as isolated in its inactive
form reveals the presence of cob(II)alamin (34), which
is consistent with the electronic absorption spectrum of
the enzyme. The EPR signal disappears upon reductive
methylation, as expected for the conversion of para-
magnetic cob(II)alamin to diamagnetic methylcobala-
mm (Fig. 3). In addition to cobalt, the E. co/i B enzyme
was found to contain 1 mol of copper per mol of
enzyme-bound cobalamin (34). The copper was tightly
bound and EPR silent in the native enzyme, but be-
came detectable when the enzyme was denatured. The
copper bound to the enzyme is in the Cu1 oxidation
state as judged by X-ray absorption edge spectroscopy
(Clark, K., Penner-Hahn, J., Banerjee, R. V., and
Matthews, R. G., unpublished results). The recom-
binant enzyme from E. co/i K-12 lacks stoichiometric
copper (it contains about 0.1 mol copper per mol
cobalamin) although its turnover number under Vmax
conditions is comparable to that of the wild-type E. co/i
B enzyme. These results lead us to conclude that cop-
per does not play a crucial catalytic role.
Methionine synthase has also been purified to
homogeneity from human placental tissue (47) and
found to contain two equivalents of iron per mol of
enzyme-bound cobalamin. The role of iron in this en-
zyme is as yet unknown. The homogeneous enzyme
from human placenta had a specific activity of 0.014
tmol mint mg protein1, measured at 37#{176}C,which
would correspond to a turnover number of 2.2 mint.
In contrast, a turnover number of 670 min’ was esti-
mated for partially purified enzyme from pig liver (7),
and a specific activity of 0.9 tmol min’ mg protein’
at 37#{176}Cwas measured for the partially purified pig kid-
ney enzyme (48). Thus there is concern that the en-
zyme isolated from human placenta (47) was grossly in-
active. The turnover number of 670 mint estimated on
the basis of cobalamin determinations in partially
purified enzyme fractions (7) is quite comparable to the
turnover number of the enzyme from E. co/i (-1300
mint at 37#{176}C)(34).
The overall reaction catalyzed by methionine syn-
thase is a transmethylation from CH3-H4folate to
homocysteine, as shown in Eq. 1, and has an equilib-
rium constant of i0 in favor of products (49). Under in
vitro assay conditions, the reaction displays an absolute
requirement for catalytic amounts of AdoMet and a
reducing system (1, 2). Inactive cob(II)alamin is
primed for turnover by a reductive methylation reac-
tion, as shown in Fig. 3. The methylated enzyme so
generated is catalytically competent and mediates the
transfer of a methyl group from CH3-H4folate to
homocysteine during turnover. However, about once in
every 100 turnovers, the enzyme is disabled by an ad-
ventitious oxidation of cob(I)alamin (50), and needs to
be reactivated for turnover by the reducing system and
AdoMet.
A variety of different activation systems have been
employed with the enzyme from E. co/i. The standard
assay includes dithiothreitol and aquocobalamin in
phosphate buffer as the source of electrons. The chemi-
cal reductants can be substituted by NADPH and two
fiavoproteins from E. co/i, designated the R and F pro-
teins (11), that have properties analogous to ferredoxin:
NADPH oxidoreductase and flavodoxin, respectively.
With the physiological reducing system, the ultimate
source of electrons is NADPH, an obligate two-electron
donor. Although the R flavoprotein undergoes a facile
two-electron reduction by NADPH, the second protein
in the electron transfer chain, the F protein, stabilizes
the one-electron reduced semiquinone state (50). Hence
the role of the two fiavoproteins in this electron wire be-
tween NADPH and methionine synthase is presumably
to mediate conversion from two to one electron transfer.
With the chemical reducing system, aquocobalamin
may assume a similar role in bridging the gap between
dithiothreitol, a two-electron donor, and methionine
synthase, a one-electron acceptor. In addition, or alter-
natively, aquocobalamin plays the role of an oxygen
scrubber, providing semianaerobic conditions for as-
says conducted with initially aerobic solutions. Apo-
enzyme from bacterial sources is inactive in assays con-
taining aquocobalamin and requires methylcobalamin
for holoenzyme formation (51).
Conversion of cob(II)alamin to cob(I)alamin is a
particularly challenging reduction in the cellular milieu
because the midpoint potential for this redox couple is
one of the lowest found in biological systems (Fig. 7).
The cob(II)alamin/cob(I)alamin couple of the aqueous
cofactor at pH 7 was determined to be -610 mV vs. the
standard hydrogen electrode (52). The reduction poten-
tial for the methionine synthase-bound cob(II)alamin/
cob(I)alamin couple was found to be -526 mV (53).
Hence, although the binding of the cofactor to the pro-
tein does render the reduction somewhat easier, reduc-
tion remains a thermodynamically unfavorable reac-
tion with the reducing partners of methionine synthase
in in vitro assays, viz. flavodoxin or dithiothreitol, as
shown in Fig. 7.
An endergonic reduction could in principle be driven
by a large free energy decrease accompanying methyla-
tion of the reduced cobalamin, if the two reactions were
coupled. Evidence for such a mechanism for reductive
methylation of methionine synthase has recently been
obtained (53). The highly exergonic methyl transfer
from AdoMet to cob(I)alamin could be used to drive a
highly endergonic reduction of the cob(II)alamin redox
center of the enzyme at potentials as high as -82 mV.
From the shift in the apparent standard potential for
the cob(II)alamin/cob(I)alamin couple in the presence
of AdoMet, G#{176}for the methyl transfer was estimated
to be greater than -9 kcal per mol. In contrast, G#{176}’
for the CH3 - H4folate-dependent methylation was cal-
culated to be -0.09 kcal per mol, and the apparent
standard potential for the cob(II)alamin/cob(I)alamin
couple in the presence of C H3 - H4folate is only shifted
to -450 mV. These results elucidate the enigmatic
requirement for AdoMet during in vitro activation,
+04
.02 cob Ilt)alam,Wcob(lI)alamin
+00 -
Si
± -
0,
- -02 -
>
0
0.
-04 -
tlavodooio oxidized/semiqu,none
threliol doulfidc/dithiothrrnol
NAl)P/NAtM’Il
flavodoxin semiquinoneThydroquinone
1)6 c.,b(ll)alanon/c,,h(l)alan.;n
.Ox
COBALAMIN-DEPENDENT METHIONINE SYNTHASE 1457
dircction of
sponlaneous
electron flow
Figure 7. Redox potential ladder demonstrating the thermo-
dynamic difficulty of reducing cob(II)alamin in the cellular milieu,
and the rationale for employing AdoMet vs. CH3-H4folate to
couple methylation of cob(L)alamin to reduction of cob(II)alamin to
cob(I)alamin. For a two electron transfer at 25#{176}C,a 30 mV poten-
tial difference corresponds to an -10-fold difference in concentra-
tions of the two species at equilibrium, and for a one electron trans-
fer, a 60 mV potential difference corresponds to an -10-fold
difference in concentrations of the two species at equilibrium. All
potentials shown are vs. the standard hydrogen electrode and are
standard potentials at pH 7.
despite the ready reaction of CH3-H4folate with
cob(I)alamin during catalytic turnover. The equilibrium
constants for the two transmethylations differ by more
than l0; hence AdoMet, but not CH3-H4folate, is
able to drive reduction of cob(II)alamin at ambient
potentials during aerobic growth and under in vitro
assay conditions.
There is no evidence for the presence of a pyridine
nucleotide-dependent activation system analogous to
the R and F protein in pig liver cells. However, several
thiols, such as homocysteine, cysteine, and dithio-
threitol, are capable of supporting methionine synthase
activity in the absence of added cobalamin (54). Par-
tially purified enzyme is associated with thiol oxidase
activity (54), as shown in Eq. 5.
Dithiothreitol + O2-#{176}Threitol disulfide + H2O2 (5)
It has been postulated that the thiol oxidase activity is
an intrinsic property of the mammalian enzyme, and
that thiols may serve as the physiological reductants for
the mammalian enzyme (54). A group of patients with
severe megaloblastic anemia and homocystinuria (but
no methylmalonic aciduria) have been described (55),
and their symptoms appear to be associated with a
genetic defect in cobalamin metabolism (cbiE). Cells
from these patients had normal methionine synthase
activity under standard assay conditions, but the en-
zyme activity was greatly reduced when measured with
suboptimal concentrations of thiol reducing agents.
Significantly, the patient’s fibroblasts were insensitive to
exposure to nitrous oxide, suggesting that methionine
synthase was inactive in these cells. Although the iden-
tity of the loci affected by the cblE mutation is
unknown, it is speculated that it affects a reducing sys-
tem analogous to that in E. co/i. Characterization of the
mutation should provide a powerful tool for under-
standing the mechanism of activation of the human
methionine synthase.
Once methylcobalamin enzyme is formed, catalysis
proceeds with alternation of demethylation and meth-
ylation as shown in Fig. 3. The stereochemistry of the
overall methyl transfer reaction from CH3 - H4folate to
homocysteine was investigated using CH3- H4folate
that was chiral at the 5-methyl position by virtue of con-
taining deuterium and tritium (56). The reaction was
found to proceed with retention of configuration at the
transferred carbon, as expected for two consecutive
methyl transfers from CH3 - H4folate to cobalamin
and then from methylcobalamin to homocysteine.
We have used stopped-flow kinetic studies to deter-
mine the kinetic competence of the cob(I)alamin and
methyicobalamin species at 25#{176}C,under rigorously
anaerobic conditions (Banerjee, R. V., Frasca, V.,
Ballou, D. P., and Matthews, R. G., unpublished data).
Under such strictly anaerobic conditions, the need for
an activation system is obviated because of the reduced
susceptibility of cob(I)alamin to oxidation. Hence, the
turnover reaction can be studied starting with the
methylcobalamin form of methionine synthase in the
absence of added AdoMet and aquocobalamin. These
experiments were performed with methylated methio-
nine synthase that had been generated by electrochemi-
cal reduction in the presence of AdoMet (53). The en-
zyme was rapidly mixed with either homocysteine or a
mixture of homocysteine and CH3 - H4folate. The for-
mation of cob(I)alamin from methylcobalamin was
monitored either by observing the increase in absorp-
tion at 390 nm or the decrease in absorption at 520 nm
(see Fig. 2). Conversely, the formation of methylcobala-
mm from cob(I)alamin was followed by monitoring the
increase in absorbance at 520 nm. In these experi-
ments, evidence has been obtained that both cob(I)ala-
mm and methylcobalamin are kinetically competent
catalytic intermediates.
Although there is good evidence for the intermediacy
of methylcobalamin in the methyl group transfer from
CH3-H4folate to homocysteine, and for the role of
cob(I)alamin as a nucleophile, the mechanism of acti-
vation of CH3- H4folate prior to nucleophilic displace-
ment of the methyl group remains obscure. A simple
SN2 displacement at the a-carbon of a tertiary amine
would constitute a chemical reaction without prece-
dent, albeit cob(I)alamin is an excellent nucleophile. As
shown in Fig. 8, the tertiary amine could be activated
by two-electron oxidation giving rise to a quaternized
sp2 nitrogen (structures I and 2), by one electron oxi-
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Figure 8. Possible activated forms of CH3-H4folate.
dation to generate the amine radical cation (structure
3), or by quaternization via protonation at N5 (struc-
ture 4). Formation of structures 1, 2, or 3 would require
an as-yet-unidentified high potential electron acceptor
on the enzyme. Whatever the mode of activation, an
understanding of the structure of the activated species
(i.e., whether N5 is trigonal or tetrahedral; charged or
neutral) would have an important bearing on the
rational design of CH3 - H4folate analogs as inhibitors
of the enzyme.
In summary, although the availability of large
amounts of the bacterial methionine synthase from
E. co/i K-12 has led to advances in our understanding of
the activation and turnover mechanisms, studies with
the mammalian enzyme have lagged behind. Although
the enzymes from the two sources share many common
properties, the activation systems appear to be differ-
ent. In particular, it is not known what factors are re-
quired for reductive activation of the mammalian en-
zyme in vivo. Nor is the mode of activation of
CH3 - H4folate preceding displacement of the methyl
group understood. An understanding of the reaction
mechanism and solution of the crystal structure of
methionine synthase holds promise for the rational de-
sign of inhibitors with potential antineoplastic activity.
Research from the authors’ laboratory has been funded in part
by National Institutes of Health grant GM24908 (to R. G. M.).
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